ArticleFrontiers in immunology2024

Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.